1. Home
  2. AXTI vs AMPH Comparison

AXTI vs AMPH Comparison

Compare AXTI & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXT Inc

AXTI

AXT Inc

HOLD

Current Price

$24.21

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$28.63

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXTI
AMPH
Founded
1986
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
1998
2014

Fundamental Metrics

Financial Performance
Metric
AXTI
AMPH
Price
$24.21
$28.63
Analyst Decision
Hold
Buy
Analyst Count
3
6
Target Price
$11.05
$31.00
AVG Volume (30 Days)
7.0M
313.7K
Earning Date
02-19-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.27
Revenue
$90,390,000.00
$723,305,000.00
Revenue This Year
N/A
$1.37
Revenue Next Year
$33.52
$4.84
P/E Ratio
N/A
$12.14
Revenue Growth
N/A
N/A
52 Week Low
$1.13
$20.39
52 Week High
$28.65
$32.69

Technical Indicators

Market Signals
Indicator
AXTI
AMPH
Relative Strength Index (RSI) 57.47 54.66
Support Level $23.60 $27.24
Resistance Level $28.65 $29.09
Average True Range (ATR) 3.25 0.83
MACD 0.43 0.06
Stochastic Oscillator 66.86 63.11

Price Performance

Historical Comparison
AXTI
AMPH

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: